Your Catalyst to a Lucrative Business
others. Increasing consciousness regarding prevention and screening of chromosomal anomalies can boost
market growth in the coming years.
Browse Details of Report @ https://www.hexaresearch.com/research-report/non-invasive-prenatal-testing-nipt-
market
However, presence of strict regulatory framework regarding approval of medical devices can hinder the
growth of the market. Lengthy approval procedures delay innovation and development of devices. In
addition, lack of skilled professionals is also expected to restrain the growth of the non-invasive
prenatal testing market.
Various techniques involved in NIPT tests include fetal cells in maternal blood tests, cell-free DNA in
maternal plasma tests, biochemical screening tests, and ultrasound detection. Cell-free DNA in
maternal plasma tests are anticipated to witness an upswing in their demand in the coming years. This
can be attributed to growing requirement for cf-DNA-based techniques in NIPT testing. In addition,
increasing government efforts for providing prenatal services are likely to stir up the demand for these
tests.
North America is considered as one of the attractive markets in the global arena. High government
spending for research and development (R&D) activities and development of whole genome
sequencing as a result of availability of technologically advanced and presence of established
healthcare research framework have been providing an upthrust to the regional market.
On the other hand, Asia Pacific is poised to exhibit noteworthy growth in the coming years. Rising
average maternal age, improving healthcare facilities, rising disposable income, and high prevalence of
chromosomal abnormalities are some of the primary growth stimulants for the regional market.
Advancing maternal age and high-risk pregnancies in China are projected to create lucrative growth
opportunities for the regional market in near future.
Countries such as Japan and China are sights of high growth rates in the region. Additionally,
improvement in healthcare facilities along with growing exposure for clinical research in India and
Australia are also projected to support the growth of the market in APAC in the coming years.
Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/clinical-
diagnostics-industry
Follow Us: